- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa
Prompt care supports mental well-being, as hidradenitis suppurativa is often associated with depression and anxiety due to its physical and social challenges.
Early intervention is essential in treating hidradenitis suppurativa (HS) due to its progressive nature and potential for severe physical and psychological impact. HS, a chronic inflammatory skin condition, often begins with painful nodules that can worsen without timely treatment, leading to abscesses, scarring, and sinus tract formation.
In this episode, Jerry Bagel, MD, Schweiger Dermatology, explains why delaying intervention increases the risk of complications and decreases the effectiveness of available therapies, making symptoms harder to manage over time. Updated guideline recommendations encouraging early intervention can help slow disease progression, alleviate pain, and improve quality of life.
Listen above or on one of these podcast services:
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
EMBARK Data Show Continued Improvements With DMD Gene Therapy
March 19th 2025Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that benefits in functional outcomes, gene expression, and muscle imaging persist 2 years after receiving the gene therapy.
Read More
